BioSIM 抗甲型流感病毒 hemagglutinin/H

BioSIM 抗甲型流感病毒 hemagglutinin/HA 抗体 (地利伏单抗)

产品基本信息

产品货号：SIM0907-1mg

英文名称：BioSIM anti-Influenza A virus hemagglutinin/HA Antibody (Diridavumab Biosimilar), Research Grade

中文名称：BioSIM 抗甲型流感病毒 hemagglutinin/HA 抗体 (地利伏单抗)，生物类似药，科研用途

CAS号：1393659-46-5

产品规格：1mg

产品类型：二抗

供应商：InvivoCrown

产品概述

BioSIM 抗甲型流感病毒 hemagglutinin/HA 抗体是一种高品质的生物类似药，专门针对甲型流感病毒的表面糖蛋白血凝素(HA)。该抗体作为地利伏单抗的生物类似物，为流感病毒感染研究提供了可靠的工具试剂。本品经过精心设计和严格的生产工艺，确保了研究级别抗体的一致性和可重复性。

生产工艺与纯化

该重组生物类似抗体是在无动物成分的设施中生产的，仅使用体外的无蛋白细胞培养技术。这种生产方式有效避免了动物源性污染的风险，确保了产品的批次间一致性。抗体经过多步骤的纯化过程，其中包括采用Protein A或G的色谱工艺，从而获得高纯度、高活性的抗体产品。

技术参数

来源宿主：Human

反应性：Influenza A virus

免疫原：该产品的免疫原信息请参考产品说明书

纯度：经过多步纯化，适用于科研应用

应用领域

该抗体可用于多种实验方法，为流感病毒研究提供多角度的技术支持：

• ELISA：适用于检测和定量甲型流感病毒血凝素蛋白
• FACS：可用于流式细胞术分析，检测细胞表面的流感病毒抗原
• Functional assay：适用于功能性研究，评估抗体对流感病毒活性的影响
• Research in vivo：可用于体内研究，探索抗体在动物模型中的抗流感病毒效果

研究领域

该抗体主要应用于流感病毒感染相关研究，为科研人员提供研究甲型流感病毒感染机制、病毒与宿主相互作用、以及潜在治疗策略开发的有力工具。

保存条件

为确保产品活性和稳定性，请遵循以下保存建议：

• 短期保存（1-2周）：建议在4°C下保存
• 中期保存（最长12个月）：请在-20°C下保存
• 长期保存：推荐在-80°C下保存

注意：为保持产品最佳性能，请避免反复冻融。建议分装保存，以减少冻融循环次数。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM Anti-Influenza A virus Hemagglutinin/HA Antibody (Diridavumab)

Product Basic Information

Catalog Number: SIM0907-1mg

English Name: BioSIM anti-Influenza A virus hemagglutinin/HA Antibody (Diridavumab Biosimilar), Research Grade

Chinese Name: BioSIM 抗甲型流感病毒 hemagglutinin/HA 抗体 (地利伏单抗)，生物类似药，科研用途

CAS Number: 1393659-46-5

Product Size: 1 mg

Product Type: Secondary Antibody

Supplier: InvivoCrown

Product Overview

BioSIM anti-Influenza A virus hemagglutinin/HA antibody is a high-quality biosimilar antibody specifically targeting the surface glycoprotein hemagglutinin (HA) of Influenza A virus. As a biosimilar to diridavumab, this antibody provides a reliable research tool for Influenza A virus infection studies. The product is carefully designed and manufactured under strict processes to ensure consistency and reproducibility at research grade.

Production & Purification

This recombinant biosimilar antibody is produced in an animal-free facility using in vitro protein-free cell culture technology. This production method effectively eliminates the risk of animal-derived contamination and ensures batch-to-batch consistency. The antibody undergoes a multi-step purification process, including Protein A or G chromatography, to obtain a high-purity and high-activity antibody product.

Technical Specifications

Host Species: Human

Reactivity: Influenza A virus

Immunogen: Please refer to the product datasheet for immunogen information

Purity: Multi-step purified, suitable for research applications

Applications

This antibody can be used in a variety of experimental methods, providing multi-angle technical support for influenza virus research:

• ELISA: Suitable for detection and quantification of Influenza A virus hemagglutinin protein
• FACS: Applicable for flow cytometry analysis to detect influenza virus antigens on cell surfaces
• Functional assay: Suitable for functional studies to evaluate the antibody's effect on influenza virus activity
• Research in vivo: Applicable for in vivo studies to explore the anti-influenza effect of the antibody in animal models

Research Fields

This antibody is mainly used in research related to Influenza A virus infection, providing researchers with a powerful tool to study infection mechanisms, virus-host interactions, and the development of potential therapeutic strategies.

Storage Conditions

To ensure product activity and stability, please follow the storage recommendations below:

• Short-term storage (1–2 weeks): Store at 4 °C
• Medium-term storage (up to 12 months): Store at –20 °C
• Long-term storage: Store at –80 °C

Note: To maintain optimal performance, please avoid repeated freeze-thaw cycles. It is recommended to aliquot the product after first use to minimize freeze-thaw cycles.

Note: The above information is subject to change due to product optimization; please consult Apexbio for the latest details.